DrugPatentWatch Database Preview
Patent: 9,446,148
» See Plans and Pricing
Summary for Patent: 9,446,148
| Title: | Carrier-antibody compositions and methods of making and using the same |
| Abstract: | Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. |
| Inventor(s): | Markovic; Svetomir N. (Rochester, MN), Nevala; Wendy K. (Rochester, MN) |
| Assignee: | Mayo Foundation for Medical Education and Research (Rochester, MN) |
| Application Number: | 14/882,327 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,446,148
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bpl | ALBUMINEX | albumin human | SOLUTION | 125644 | 1 | 2020-05-27 | Start Trial | Mayo Foundation for Medical Education and Research (Rochester, MN) | 2034-10-06 | search | ||
| Kedrion S.p.a | KEDBUMIN | albumin (human) | INJECTION, SOLUTION | 125384 | 1 | 2011-09-15 | Start Trial | Mayo Foundation for Medical Education and Research (Rochester, MN) | 2034-10-06 | search | ||
| Octapharma Usa Inc | ALBUMIN (HUMAN) | albumin human | SOLUTION | 125154 | 1 | 2006-10-17 | Start Trial | Mayo Foundation for Medical Education and Research (Rochester, MN) | 2034-10-06 | search | ||
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 002 | 2004-02-26 | Start Trial | Mayo Foundation for Medical Education and Research (Rochester, MN) | 2034-10-06 | RX | search | |
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | Start Trial | Mayo Foundation for Medical Education and Research (Rochester, MN) | 2034-10-06 | RX | search | |
| Csl Behring Llc | ALBUMINAR-25 | albumin (human) | SOLUTION | 103955 | 1 | 2009-01-06 | Start Trial | Mayo Foundation for Medical Education and Research (Rochester, MN) | 2034-10-06 | search | ||
| Grifols Usa, Llc | HUMAN ALBUMIN GRIFOLS | albumin (human) | SOLUTION | 103352 | 1 | 2003-06-11 | Start Trial | Mayo Foundation for Medical Education and Research (Rochester, MN) | 2034-10-06 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,446,148
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201701244 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2016057554 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2017031368 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2017062063 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2017176265 | Start Trial |
| United States of America | 10300016 | Start Trial |
| United States of America | 10322084 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
